{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:17:10Z","timestamp":1649211430206},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","cancergeneticsjournal.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.cancergen.2015.12.008","type":"journal-article","created":{"date-parts":[[2015,12,23]],"date-time":"2015-12-23T09:15:26Z","timestamp":1450862126000},"page":"82-86","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells"],"prefix":"10.1016","volume":"209","author":[{"given":"Veronica","family":"Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gihan","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William","family":"Ehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mendiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gopalrao","family":"Velagaleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2015.12.008_bib0010","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cancergencyto.2008.11.007","article-title":"Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment","volume":"189","author":"Pozdnyakova","year":"2009","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0015","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1182\/blood-2011-05-355743","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS)","volume":"118","author":"Mailankody","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0020","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1309\/AJCPF7NFLW8UAJEP","article-title":"Detection of genomic abnormalities in multiple myeloma","volume":"136","author":"Hartmann","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2006.11.015","article-title":"Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark","volume":"174","author":"Christensen","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cancergencyto.2010.11.002","article-title":"The prognostic significance of cytogenetic and molecular profiling in multiple myeloma","volume":"204","author":"Sawyer","year":"2011","journal-title":"Cancer Genet"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0035","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/gcc.20809","article-title":"Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia","volume":"49","author":"Put","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0040","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1158\/0008-5472.CAN-03-2876","article-title":"Genetics and cytogenetics of multiple myeloma: a workshop report","volume":"64","author":"Fonseca","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0045","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5858\/arpa.2012-0209-OA","article-title":"Plasma cell enrichment enhances detection of high-risk cytogenomic abnormalities by fluorescence in situ hybridization and improves risk stratification of patients with plasma cell neoplasms","volume":"137","author":"Lu","year":"2013","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1751-553X.2012.01433.x","article-title":"Application of an immune-magnetic cell sorting method for CD138-positive plasma cells in FISH analysis of multiple myeloma","volume":"34","author":"Shin","year":"2012","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0055","doi-asserted-by":"crossref","first-page":"e2011047","DOI":"10.4084\/mjhid.2011.047","article-title":"Therapy-related myeloid malignancies in myeloma","volume":"3","author":"Papanikolaou","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cancergencyto.2005.01.006","article-title":"Targeting plasma cells improves detection of cytogenetic aberrations in multiple myeloma: phenotype\/genotype fluorescence in situ hybridization","volume":"158","author":"Slovak","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0065","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1182\/blood.V66.2.380.380","article-title":"The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis","volume":"66","author":"Dewald","year":"1985","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0165-4608(94)00284-I","article-title":"Cytogenetic finding in 200 patients with multiple myeloma","volume":"82","author":"Sawyer","year":"1995","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0075","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V98.7.2229","article-title":"Hypodiploidy is a major prognostic factor in multiple myeloma","volume":"98","author":"Smadja","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergen.2015.12.008_bib0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.4103\/1110-1067.153978","article-title":"CD138 expression in plasma cells is volatile and time-lag dependent","volume":"39","author":"Dorwal","year":"2014","journal-title":"Egypt J Haematol"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776215002562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T04:51:11Z","timestamp":1599972671000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776215002562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2210776215002562"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.008","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells","name":"articletitle","label":"Article Title"},{"value":"Cancer Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cancergen.2015.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}